Retraction: Mammalian Target of Rapamycin Inhibitors for Treatment in Tuberous Sclerosis

Korean Journal of Pediatrics - South Korea
doi 10.3345/kjp.2013.56.6.269
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Korean Pediatric Society

Related search

Loss of Tuberous Sclerosis Complex-2 Function and Activation of Mammalian Target of Rapamycin Signaling in Endometrial Carcinoma

Clinical Cancer Research
Cancer ResearchOncology
2008English

Tuberous Sclerosis Complex Suppression in Cerebellar Development and Medulloblastoma: Separate Regulation of Mammalian Target of Rapamycin Activity and P27Kip1 Localization

Cancer Research
Cancer ResearchOncology
2009English

Mammalian Target of Rapamycin and Caspase Inhibitors in Polycystic Kidney Disease

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2008English

Successful Treatment of Subungual Fibromas of Tuberous Sclerosis With Topical Rapamycin

JAMA Dermatology
DermatologyMedicine
2014English

Signaling Events Downstream of Mammalian Target of Rapamycin Complex 2 Are Attenuated in Cells and Tumors Deficient for the Tuberous Sclerosis Complex Tumor Suppressors

Cancer Research
Cancer ResearchOncology
2009English

Efficacy of Rapamycin in Tuberous Sclerosis–Associated Hypopigmented Macules

JAMA Dermatology
DermatologyMedicine
2015English

Mammalian Target of Rapamycin: A Target for (Lung) Diseases and Aging

Annals of the American Thoracic Society
PulmonaryRespiratory Medicine
2016English

Emerging Role for Mammalian Target of Rapamycin in Male Fertility

Trends in Endocrinology and Metabolism
EndocrinologyMetabolismDiabetes
2017English

Rapamycin Prevents Epilepsy in a Mouse Model of Tuberous Sclerosis Complex

Annals of Neurology
Neurology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy